Christine Jenkins's Publications

• Effect on health-related quality of life of ongoing feedback during a 12-month maintenance walking programme in patients with COPD: a randomized controlled trial

  Journal articles

  2018

  Respirology

• Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology

  Journal articles

  2018

  Journal of Allergy and Clinical Immunology

• Effects of ground-based walking training on daily physical activity in people with COPD: A randomised controlled trial

  Journal articles

  2017

  Respiratory Medicine

• Sputum IL-1 beta is reduced with Azithromycin add-on therapy in patients with poorly controlled asthma

  Conference Papers

  2017

  EUROPEAN RESPIRATORY JOURNAL

• Eliminating asthma deaths: have we stalled?

  Journal articles

  2017

  The Lancet

• The paradoxes of asthma management: Time for a new approach?

  Journal articles

  2017

  European Respiratory Journal

• Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial

  Journal articles

  2017

  The Lancet

• Physical activity patterns and clusters in 1001 patients with COPD

  Journal articles

  2017

  Chronic Respiratory Disease

• Perspectives on advance care planning among patients recently requiring non-invasive ventilation for acute respiratory failure: A qualitative study using thematic analysis

  Journal articles

  2017

  Palliative Medicine

• Azithromycin Reduces Exacerbations In Adults With Persistent Symptomatic Eosinophilic Asthma

  Conference Papers

  2017

  AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

• The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials

  Journal articles

  2017

  International Journal of COPD

• More action to address the impact of smoking in women

  Journal articles

  2017

  American Journal of Respiratory and Critical Care Medicine

• Efficacy of budesonideformoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment

  Journal articles

  2017

  BMC Pulmonary Medicine

• CHARACTERISTICS OF PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE WHO RESPOND TO GROUND-BASED WALKING TRAINING

  Conference Papers

  2017

  RESPIROLOGY

• THE EFFECT ON HRQoL OF ONGOING FEEDBACK DURING A MAINTENANCE WALKING PROGRAM : AN RCT

  Conference Papers

  2017

  RESPIROLOGY

• CHOOSING A FASTER WALKING SPEED FOR THE ENDURANCE SHUTTLE WALK TEST MAY REDUCE THE CEILING EFFECT FOR THIS TEST IN PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  Conference Papers

  2017

  RESPIROLOGY

• Improving the Management of COPD inWomen

  Journal articles

  2017

  Chest

• AZITHROMYCIN REDUCES EXACERBATIONS IN ADULTS WITH PERSISTENT SYMPTOMATIC EOSINOPHILIC ASTHMA

  Conference Abstracts

  2017

  RESPIROLOGY

• AN ANALYSIS OF THE EFFECT OF AZITHROMYCIN IN PERSISTENT ASTHMA, BASED ON PRE-SPECIFIED ASTHMA PHENOTYPES

  Conference Abstracts

  2017

  RESPIROLOGY

• Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

  Journal articles

  2017

  Clinical and Translational Allergy

• Early efficacy of budesonideformoterol in patients with moderate-to-very-severe COPD

  Journal articles

  2017

  International Journal of COPD

• Drugs for chronic obstructive pulmonary disease

  Journal articles

  2017

  Australian Prescriber

• WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 Area 5)

  Journal articles

  2017

  Alergologia Polska - Polish Journal of Allergology

• Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

  Journal articles

  2016

  Clinical and Experimental Allergy

• Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

  Journal articles

  2016

  INTERNAL MEDICINE JOURNAL

• Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

  Journal articles

  2016

  Internal Medicine Journal